Brief: Aptinyx Completes Enrollment In Phase 2 Exploratory Study Of NYX-783
18/06/2020 12:58
June 18 (Reuters) - Aptinyx Inc APTX.O :
* APTINYX COMPLETES ENROLLMENT IN PHASE 2 EXPLORATORY STUDY
OF
NYX-783 IN POST-TRAUMATIC STRESS DISORDER
* APTINYX INC - ANTICIPATES REPORTING DATA FROM STUDY OF
NYX-783
IN LATE 2020
Source text for Eikon: ID:nGNX70mpcs
Further company coverage: APTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aptinyx
See all newsBrief: Aptinyx Gets Notice Of Delisting Or Failure To Satisfy Continued Listing Rule From Nasdaq
Brief: Aptinyx Inc reports On May 4, Board Deemed It In Best Interests Of Co And Its Stockholders That Co Be Dissolved
Aptinyx Inc reports results for the quarter ended in December - Earnings Summary
Brief: Aptinyx Inc Reports Quarterly Loss Per Share Of $0.18
Aptinyx Inc expected to post a loss of 19 cents a share - Earnings Preview